Edition:
United States

AstraZeneca PLC (AZN)

AZN on New York Consolidated

29.16USD
17 Feb 2017
Change (% chg)

$0.40 (+1.39%)
Prev Close
$28.76
Open
$29.16
Day's High
$29.27
Day's Low
$28.93
Volume
4,496,430
Avg. Vol
7,280,827
52-wk High
$35.04
52-wk Low
$25.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 18 Feb 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.20 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 2 5,210.00 5,375.00 5,045.00 5,445.00
Quarter Ending Jun-17 2 5,174.50 5,270.00 5,079.00 5,365.00
Year Ending Dec-17 5 21,363.50 21,770.00 20,796.00 23,374.90
Year Ending Dec-18 4 22,012.30 23,319.40 20,457.00 24,347.30
Earnings (per share)
Year Ending Dec-17 3 1.82 1.84 1.81 2.03
Year Ending Dec-18 3 1.98 2.01 1.95 2.81
LT Growth Rate (%) 1 8.50 8.50 8.50 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 5,432.29 5,585.00 152.71 2.81
Quarter Ending Sep-16 5,945.79 5,699.00 246.79 4.15
Quarter Ending Jun-16 5,561.06 5,603.00 41.94 0.75
Quarter Ending Mar-16 5,963.93 6,115.00 151.07 2.53
Quarter Ending Dec-15 6,271.17 6,207.00 64.17 1.02
Earnings (per share)
Quarter Ending Dec-16 0.58 0.61 0.03 4.27
Quarter Ending Sep-16 0.74 0.66 0.08 10.81
Quarter Ending Jun-16 0.76 0.83 0.07 9.21
Quarter Ending Mar-16 0.48 0.48 0.00 0.00
Quarter Ending Dec-15 0.88 0.47 0.41 46.59

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 5,210.00 5,210.00 5,375.00 5,555.00 5,445.00
Quarter Ending Jun-17 5,174.50 5,174.50 5,270.00 5,415.00 5,365.00
Year Ending Dec-17 21,363.50 21,363.50 21,422.80 21,556.80 23,374.90
Year Ending Dec-18 22,012.30 22,012.30 22,171.30 22,426.30 24,347.30
Earnings (per share)
Year Ending Dec-17 1.82 1.82 1.84 1.84 2.03
Year Ending Dec-18 1.98 1.98 1.95 1.95 2.81

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 0 0
Quarter Ending Jun-17 0 0 0 0
Year Ending Dec-17 0 0 1 3
Year Ending Dec-18 0 0 0 2
Earnings
Year Ending Dec-17 0 0 0 3
Year Ending Dec-18 0 0 0 0

More From Around the Web